Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$106000.0.

  • SOPHiA GENETICS's Capital Expenditures fell 3947.37% to -$106000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$251000.0, marking a year-over-year increase of 1955.13%. This contributed to the annual value of -$244000.0 for FY2024, which is 8366.8% up from last year.
  • SOPHiA GENETICS's Capital Expenditures amounted to -$106000.0 in Q3 2025, which was down 3947.37% from -$57000.0 recorded in Q4 2024.
  • SOPHiA GENETICS's Capital Expenditures' 5-year high stood at -$12000.0 during Q2 2024, with a 5-year trough of -$1.9 million in Q4 2022.
  • For the 5-year period, SOPHiA GENETICS's Capital Expenditures averaged around -$507294.1, with its median value being -$151000.0 (2021).
  • As far as peak fluctuations go, SOPHiA GENETICS's Capital Expenditures plummeted by 139651.16% in 2021, and later surged by 9837.4% in 2024.
  • Quarter analysis of 5 years shows SOPHiA GENETICS's Capital Expenditures stood at -$151000.0 in 2021, then crashed by 1172.19% to -$1.9 million in 2022, then soared by 93.49% to -$125000.0 in 2023, then skyrocketed by 54.4% to -$57000.0 in 2024, then plummeted by 85.96% to -$106000.0 in 2025.
  • Its last three reported values are -$106000.0 in Q3 2025, -$57000.0 for Q4 2024, and -$76000.0 during Q3 2024.